FDA Adverse Event Malfunction Summary report: N

EVIS EXERA III COLONOVIDEOSCOPE

MDR report key: 22193969 · Received June 12, 2025

Report

Report Number
9610595-2025-11021
Event Type
Malfunction
Date Received
June 12, 2025
Date of Event
May 19, 2025
Report Date
June 12, 2025
Manufacturer
AIZU OLYMPUS CO., LTD.
Product Code
FDF
PMA / PMN Number
K192793
Removal / Correction Number
CAPA-201632
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
IT
Reporter Occupation
003

Narratives

Additional Manufacturer Narrative · 0

THE DEVICE WAS RETURNED TO OLYMPUS FOR INSPECTION. A ROOT CAUSE COULD NOT BE IDENTIFIED. BASED ON THE RESULTS OF THE INVESTIGATION, IT IS LIKELY THE FOLLOWING LED TO THE MALFUNCTION: THE CAUSE WAS NOT ESTABLISHED. A CAPA HISTORY REVIEW WAS PERFORMED AND CAPA-201632 WAS IDENTIFIED TO BE RELATED TO THE FAILURE "AW-TUBE HAS FOREIGN OBJECTS". THE WHITE FOREIGN MATERIAL DETECTED BY INCOME INSPECTION HAS BEEN HANDLED BY OMSC CAPA-201632. ACCORDING TO PREVIOUS INVESTIGATIONS, THE USE OF PRODUCTS THAT CONTAIN SILICONE CAN CAUSE DEPOSITS OF WHITE FOREIGN MATERIAL. SILICONE IS FOR EXAMPLE INCLUDED IN SIMETHICONE, A DEFOAMING AGENT, LUBRICANTS AND SO ON. IF THE CUSTOMER USED THEM, THERE WAS RISK THAT FOREIGN MATERIAL REMAINED IN THE CHANNEL EVEN IF THE REPROCESSING WAS CONDUCTED IN ACCORDANCE WITH IFU. SIMETHICONE AND PETROLEUM/OIL/SILICONE-BASED LUBRICANTS ARE NON-WATER SOLUBLE AND THUS NOT RECOMMENDED FOR USE BY OLYMPUS. THE CAPA IS IN OPEN STATUS. THE CAPA OWNER WAS INFORMED ABOUT THIS COMPLAINT. SHOULD ADDITIONAL RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED. OLYMPUS WILL CONTINUE TO MONITOR FIELD PERFORMANCE FOR THIS DEVICE.

Description of Event or Problem · 0

IT WAS OBSERVED THAT DURING THE DEVICE EVALUATION, THE COLONOVIDEOSCOPE EXHIBITED FOREIGN MATERIAL IN THE AIR/WATER TUBE. THERE WAS NO PATIENT INVOLVEMENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2200294 EVIS EXERA III COLONOVIDEOSCOPE COLONOVIDEOSCOPE FDF AIZU OLYMPUS CO., LTD. PCF-H190TL

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown